Close
Almac
Achema middle east

News

Abzena upgrades GMP chemistry and conjugation suites to allow Phase III and commercial manufacturing

Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites. The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from...

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect (18 November – 18 December, 2020) for international audiences unable to attend. The physical exhibition will be...

SIRIO launches first smart nutra factory in Ma’anshan

SIRIO – a leading nutraceutical contract development and manufacturing organisation (CDMO) – has completed a new ‘smart factory’ at its Ma’anshan site, with Internet of Things (IoT) enabled automated processes and monitoring, intelligent distribution robotics and Artificial intelligence (AI). Sirio...

Onyx Scientific prepares for commercial API license with UK facility investment

Onyx Scientific has announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license. The new facility, which represents a £3m investment, is currently in the design...

New RF Series Benchtop Bottle / Vial Filler Robot for Liquid Filling and Capping Operations

Dispense Works Inc. now offers the RF 2415 Robot that will streamline your filling and capping operations with one precise and affordable bench top package. This dispensing machine is able to process bottles, tubes, vials with caps screwed on...

New guidelines for independent batch control of COVID-19 vaccines by EU laboratories

Three new Official Control Authority Batch Release (OCABR) guidelines outlining the tests to be performed by the EU’s Official Medicines Control Laboratories (OMCLs) will be part of the independent control of COVID-19 vaccine batches, when they become available in...

Pioneering research potentially reveals early detection of prostate cancer

Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »